Defence and Adaptation in Drug-Mediated Liver Toxicity Christopher Goldring, University of Liverpool, speaking at ADME & Predictive Toxicology Europe 2012
Improvement of Cell Culture Technology for Primary Cells and Stem Cell Manipulation Dr Veit Bergendahl, Miltenyi Biotec GmbH, speaking at Cell Culture 2012
Companies in Translation with CIRM Dr Alan Trounson, California Institute for Regenerative Medicine, speaking at Stem Cells 2012
The Bavarian Red Cross Blood Donor BioBank - the First Successful Combination of Blood Donation and Biobanking Christine Zoglmeier, Bavarian Red Cross Blood Donor BioBank, speaking at World Biobanking Summit 2011.
Wither Biobanking for Cancer? Building our Reserves or, a Spending Spree? Malcolm Mason, Director of the Wales Cancer Bank, speaking at World Biobanking Summit 2011.
Utilising Informatics to Add Value to Banked Samples Jane Rogan, Manchester Cancer Research Centre Biobank, speaking at World Biobanking Summit 2011.
Hospital Integrated Biobanking and Prospective Cancer Biobanking (U-Can) Anna Beskow, Director of Uppsala Biobank, speaking at World Biobanking Summit 2011.
From Acquisition to Analysis: Tools to Improve the High Content Screening Workflow for Stem Cell Assays Ben Haworth, Molecular Devices, speaking at Screening Europe 2011.
Epithelial-to-mesenchymal Transition Leads to the Acquisition of Cancer Stem Cell Characteristics in Liver Cancer Bart Rountree, Assistant Professor, Penn State College of Medicine speaking at Stem Cells World Congress 2011